MedTrace Logo

Effect of Anti-hypertensive Medications on the Diagnostic Accuracy in Primary Aldosteronism

NCT04991961 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 341

Last updated 2025-08-14

No results posted yet for this study

Summary

To evaluate the effect of anti-hypertensive medication on efficiency of primary aldosteronism screening and confirmatory test, and to determine the appropriate diagnostic cutoff value for Chinese hypertension patients during antihypertensive drugs therapy.

Conditions

Interventions

DIAGNOSTIC_TEST

withdraw antihypertensive drugs

patients need to withdraw of all antihypertensive drugs or change therapy to Doxazosin/Diltiazem for 2-4 weeks prior

Sponsors & Collaborators

  • Chongqing Medical University

    lead OTHER

Principal Investigators

  • Li Qifu, PhD · First Affiliated Hospital of Chongqing Medical University

Eligibility

Min Age
10 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-15
Primary Completion
2024-10-31
Completion
2024-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04991961 on ClinicalTrials.gov